Determinants of treatment in patients with stage IV renal cell carcinoma

BACKGROUND: Advances in systemic targeted therapies afford treatment opportunities in patients with metastatic renal cell carcinoma (RCC). Elderly patients with metastatic RCC present a subpopulation for consideration owing to competing causes of mortality and benefits seen with new therapeutic agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollenbeak, Christopher S., Schaefer, Eric W., Doan, Justin, Raman, Jay D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883608/
https://www.ncbi.nlm.nih.gov/pubmed/31783828
http://dx.doi.org/10.1186/s12894-019-0559-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883608/
https://www.ncbi.nlm.nih.gov/pubmed/31783828
http://dx.doi.org/10.1186/s12894-019-0559-0

Ejemplares similares